— Baxter International Inc. (NYSE: BAX) reported third-quarter 2019 revenues of $2.85 billion, up 3% YoY, vs. $2.86 billion expected.
— Operating income on an adjusted basis totaled $555 million, or 19.5% of sales.
— The company has launched an internal probe into transactions undertaken for the purpose of generating foreign exchange gains or losses. The transactions used a convention that was not in accordance with GAAP, leading to some misstatements in the previously reported operating income. Baxter did not give an end date for the probe.
— For 4Q19, Baxter sees sales growth of 3-4% on a reported basis and approximately 5% on a constant currency basis. Operating margin is expected between 15.2% and 15.9% on a reported basis and between 18.5% and 19% on an adjusted basis.
— BAX shares fell 6.5 immediately following the earnings announcement.
Most Popular
CVX Earnings: Chevron reports lower revenue and profit for Q1 2024
Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or
ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was